| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
5 companies
Venrock Healthcare Capital Partners III, L.P. is 10% Owner at LYCA, with reported holdings spanning 5 companies. From May 2020 to October 2026, the filings on record show 19 open-market purchases and 0 sales.
Our model assigns Venrock Healthcare Capital Partners III, L.P. a middling insider score of 54/100, based on 37 past trades. Over a 12-month horizon, 37.8% of those trades were profitable, with an average 12-month return of +9.6%.
Venrock Healthcare Capital Partners III, L.P.'s largest disclosed position is in ORKA as 10% Owner, worth about $413.0M. Net of sales, the ORKA filings show accumulation of 122,882 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2024 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 99,129 | $12.53 | $1,241,684.52 | +2.2% | -7.8% | -28.0% | |
| Jan 19, 2024 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 143,605 | $12.55 | $1,801,601.80 | +3.3% | -7.3% | -33.1% | |
| Jan 16, 2024 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 26,246 | $12.72 | $333,779.23 | +0.6% | -8.5% | -38.7% | |
| Jan 10, 2024 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 137,700 | $12.54 | $1,726,456.92 | +3.3% | -7.1% | -38.2% | |
| Jan 4, 2024 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 59,369 | $12.14 | $720,543.04 | +1.5% | -4.0% | -23.0% | |
| Dec 29, 2023 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 519,017 | $12.46 | $6,465,649.95 | +14.5% | -3.2% | -30.4% | |
| Aug 18, 2020 | COGT Cogent Biosciences, Inc. | 10% Owner | Buy | 451,000 | $2.52 | $1,137,120.00 | +11.6% | - | - | |
| Jun 15, 2020 | ALT Altimmune, Inc. | 10% Owner | Buy | 1,500,000 | $7.54 | $11,310,000.00 | +50.0% | - | - | |
| May 28, 2020 | ALT Altimmune, Inc. | 10% Owner | Buy | 1,303,636 | $8.74 | $11,395,493.13 | +76.8% | - | - |